Tampere, FIN-33101
Finland
elimination, eradication, gender-neutral vaccination, human papillomavirus, prevalence
cluster-randomized trial, core-group, herd effect, herpes simplex virus type-2, human papillomavirus, hybrid study design, type-replacement, vaccination